FRI-158-Bone and renal safety are improved in chronic HBV patients switched to tenofovir alafenamide (TAF) after either 2 or 3 years of prior tenofovir disoproxil fumarate (TDF) treatment
Autor: | Tabak Fehmi, Edward Gane, Jia-Horng Kao, Audrey H. Lau, Anuj Gaggar, Vithika Suri, Wan-Long Chuang, Elena Nurmukhametova, Scott Fung, Harry L.A. Janssen, Young-Suk Lim, Shuyuan Mo, Abhijit Chaudhuri, Maciej Jabłkowski, Adrian Streinu-Cercel, Namiki Izumi, Xiaoli Ma, John F. Flaherty, Maria Buti |
---|---|
Rok vydání: | 2019 |
Předmět: | |
Zdroj: | Journal of Hepatology. 70:e457-e458 |
ISSN: | 0168-8278 |
Databáze: | OpenAIRE |
Externí odkaz: |